WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Bayer

The Bayer GroupBayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed 118,900 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion.

www.bayer.com.

Bayer RSS Channel

Filters
List of articles in category Bayer
Title Published Date
Bayer's Stivarga® (regorafenib) tablets approved by FDA for treatment of patients with gastrointestinal stromal tumors 25 February 2013
Bayer receives approval for new long-term contraceptive Skyla™ in the U.S. 09 January 2013
Bayer's "Perspective on Innovation 2012" 15 November 2012
The largest clinical study of Bayer's Xarelto® (rivaroxaban) 13 November 2012
Bayer on track for a successful 2012 30 October 2012
Bayer's Stivarga® (regorafenib) tablets approved by FDA for treatment of metastatic colorectal cancer 30 September 2012
Bayer joins global initiative for better access to safe and effective contraception 26 September 2012
Bayer HealthCare starts special lab space-model CoLaborator™ for promising life science companies 11 September 2012
Bayer reports strong business performance in the second quarter of 2012 31 July 2012
FDA grants priority review to the new drug application for Bayer's Regorafenib 28 June 2012
Bayer's Regorafenib submitted for EU and US marketing authorization 23 May 2012
Encouraging start to the year for Bayer 26 April 2012
Bayer HealthCare and Beijing's Tsinghua University extend innovative drug discovery partnership 28 March 2012
Bayer HealthCare to Share Lab Space with Start-Up Companies 09 January 2012
Four potential blockbusters in the Pharma pipeline 20 December 2011
Bayer plans further expansion in Asia 16 November 2011
After a good third quarter: Bayer confirms Group outlook 28 October 2011
Bayer HealthCare and Onyx Pharmaceuticals Restructure Global Oncology Partnership 17 October 2011
Bayer Confident in Results of ROCKET AF Study 07 September 2011
Bayer Healthcare to acquire Pathway Medical Technologies 01 September 2011
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Business & Industry

  • Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
  • Bayer transforms pharma business through breakthrough innovation in healthcare
  • Valneva in advanced discussions with European Commission to supply up to 60 million doses of inactivated, adjuvanted COVID-19 vaccine candidate
  • An in vitro study shows Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with a mutation associated with rapid transmission
  • European Commission authorizes COVID-19 vaccine Moderna in Europe

Research & Development

  • New England Journal of Medicine publishes COVID-19 treatment trial results
  • Scientists identify 'immune cop' that detects SARS-CoV-2
  • New findings help explain how COVID-19 overpowers the immune system
  • New virtual screening strategy identifies existing drug that inhibits COVID-19 virus
  • Sustained cellular immune dysregulation in individuals recovering from COVID-19
  • How SARS-CoV-2 interacts with cells
  • Neutralizing antibodies protect against severe COVID-19

Conferences & Events

  • CPhI Worldwide to return in 2021
  • Reuters Events' Cell & Gene Therapy USA
  • Total health: Build a better healthcare system
  • Don't fall for the 'next best action' trap
  • Locking down shape-shifting spike protein aids development of COVID-19 vaccine
  • COVID-19 vaccine innovation could dramatically speed up worldwide production
  • Wearable Injectors and Connected Devices Conference 2020

Regulatory Affairs

  • EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
  • FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine
  • Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application
  • FDA takes key action in fight against COVID-19 by issuing Emergency Use Authorization for first COVID-19 vaccine
  • EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2
  1. You are here:  
  2. Home
  3. Bayer
  4. Bayer transforms pharma business through breakthrough innovation in healthcare

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2021. All Rights Reserved.